This document provides an overview of glomerular disease and proteinuria in dogs. It begins with a discussion of laboratory evaluation of proteinuria including urinalysis and urine protein to creatinine ratio testing. Pathophysiology of proteinuria is then reviewed including mechanisms in the glomerulus, tubules, and factors causing extra-renal proteinuria. Common causes of pathologic renal proteinuria are listed. The diagnostic workup for proteinuria is outlined including recommendations for additional testing based on urinary protein levels and presence of azotemia. Renal biopsy indications and contraindications are reviewed. Treatment options including ACE inhibitors, diet, immunosuppression, and managing hypertension are summarized. Factors impacting prognosis like severity
This document discusses extrahepatic and intrahepatic cholestasis. Extrahepatic cholestasis is obstructive, occurring outside the liver in the lumen or wall. Intrahepatic cholestasis is hepatocellular, occurring inside the liver. Causes of cholestasis include hereditary conditions like Dubin-Johnson syndrome and Rotor's syndrome, as well as acquired conditions such as acute hepatitis, liver cirrhosis, and certain drugs. Clinical manifestations of cholestasis are yellowed skin, dark urine, pale stool, and pruritis.
This document discusses several viral infections that can present with fever and rash, including measles, rubella, and chickenpox. It describes the causative agents, modes of transmission, incubation periods, clinical manifestations like rash appearance and progression, potential complications, treatments, and importance of vaccination.
Dr. Sachin Verma is a young, diligent and dynamic physician. He did his graduation from IGMC Shimla and MD in Internal Medicine from GSVM Medical College Kanpur. Then he did his Fellowship in Intensive Care Medicine (FICM) from Apollo Hospital Delhi. He has done fellowship in infectious diseases by Infectious Disease Society of America (IDSA). He has also done FCCS course and is certified Advance Cardiac Life support (ACLS) and Basic Life Support (BLS) provider by American Heart Association. He has also done a course in Cardiology by American College of Cardiology and a course in Diabetology by International Diabetes Centre. He specializes in the management of Infections, Multiorgan Dysfunctions and Critically ill patients and has many publications and presentations in various national conferences under his belt. He is currently working in NABH Approved Ivy super-specialty Hospital Mohali as Consultant Intensivists and Physician.
This document defines jaundice and discusses its various causes and mechanisms. Jaundice is caused by an increased bilirubin level in body fluids and can be due to increased production from hemolysis, impaired excretion from conditions like liver disease, or obstruction of bile flow from the liver or gallbladder. The causes, signs, investigations, and approach to evaluating a patient with jaundice are described.
Mrs Mariapalam, a 61-year-old woman, was admitted with fever, breathlessness, and joint pain. Initial tests showed pericardial effusion, hypothyroidism, and an equivocal leptospirosis test. She was started on antitubercular treatment but symptoms persisted. Further evaluation at a new hospital found pleural effusions, pneumonia, positive antinuclear antibody and low complement levels, consistent with a diagnosis of lupus pneumonitis. She improved dramatically on high-dose intravenous steroids.
Sabah ( Malaysia) rheumatology update gout 2016DrAlan83
This document discusses the optimal management of gout. It reviews case notes of patients taking NSAIDs for gouty arthritis who experienced upper gastrointestinal bleed. The results showed 60% were taking NSAIDs for gouty arthritis. It emphasizes aiming to lower serum uric acid levels to below 6 mg/dl, as this saturation point prevents new crystal formation and dissolution of existing crystals, eliminating gout attacks and reducing tophus size. Evidence shows maintaining uric acid levels below 6 mg/dl is correlated with fewer gout attacks. The document outlines evaluating and managing acute gout flares as well as initiating urate-lowering therapy such as allopurinol or probenecid to dissolve urate crystals and
1. Acute post-streptococcal glomerulonephritis (APSGN) is a type of acute nephritic syndrome that occurs after a streptococcal infection.
2. It is characterized by edema, hematuria, proteinuria, and decreased kidney function.
3. The infection triggers an immune response where antibodies form complexes that deposit along the glomerular basement membrane, causing inflammation and kidney damage.
This document discusses extrahepatic and intrahepatic cholestasis. Extrahepatic cholestasis is obstructive, occurring outside the liver in the lumen or wall. Intrahepatic cholestasis is hepatocellular, occurring inside the liver. Causes of cholestasis include hereditary conditions like Dubin-Johnson syndrome and Rotor's syndrome, as well as acquired conditions such as acute hepatitis, liver cirrhosis, and certain drugs. Clinical manifestations of cholestasis are yellowed skin, dark urine, pale stool, and pruritis.
This document discusses several viral infections that can present with fever and rash, including measles, rubella, and chickenpox. It describes the causative agents, modes of transmission, incubation periods, clinical manifestations like rash appearance and progression, potential complications, treatments, and importance of vaccination.
Dr. Sachin Verma is a young, diligent and dynamic physician. He did his graduation from IGMC Shimla and MD in Internal Medicine from GSVM Medical College Kanpur. Then he did his Fellowship in Intensive Care Medicine (FICM) from Apollo Hospital Delhi. He has done fellowship in infectious diseases by Infectious Disease Society of America (IDSA). He has also done FCCS course and is certified Advance Cardiac Life support (ACLS) and Basic Life Support (BLS) provider by American Heart Association. He has also done a course in Cardiology by American College of Cardiology and a course in Diabetology by International Diabetes Centre. He specializes in the management of Infections, Multiorgan Dysfunctions and Critically ill patients and has many publications and presentations in various national conferences under his belt. He is currently working in NABH Approved Ivy super-specialty Hospital Mohali as Consultant Intensivists and Physician.
This document defines jaundice and discusses its various causes and mechanisms. Jaundice is caused by an increased bilirubin level in body fluids and can be due to increased production from hemolysis, impaired excretion from conditions like liver disease, or obstruction of bile flow from the liver or gallbladder. The causes, signs, investigations, and approach to evaluating a patient with jaundice are described.
Mrs Mariapalam, a 61-year-old woman, was admitted with fever, breathlessness, and joint pain. Initial tests showed pericardial effusion, hypothyroidism, and an equivocal leptospirosis test. She was started on antitubercular treatment but symptoms persisted. Further evaluation at a new hospital found pleural effusions, pneumonia, positive antinuclear antibody and low complement levels, consistent with a diagnosis of lupus pneumonitis. She improved dramatically on high-dose intravenous steroids.
Sabah ( Malaysia) rheumatology update gout 2016DrAlan83
This document discusses the optimal management of gout. It reviews case notes of patients taking NSAIDs for gouty arthritis who experienced upper gastrointestinal bleed. The results showed 60% were taking NSAIDs for gouty arthritis. It emphasizes aiming to lower serum uric acid levels to below 6 mg/dl, as this saturation point prevents new crystal formation and dissolution of existing crystals, eliminating gout attacks and reducing tophus size. Evidence shows maintaining uric acid levels below 6 mg/dl is correlated with fewer gout attacks. The document outlines evaluating and managing acute gout flares as well as initiating urate-lowering therapy such as allopurinol or probenecid to dissolve urate crystals and
1. Acute post-streptococcal glomerulonephritis (APSGN) is a type of acute nephritic syndrome that occurs after a streptococcal infection.
2. It is characterized by edema, hematuria, proteinuria, and decreased kidney function.
3. The infection triggers an immune response where antibodies form complexes that deposit along the glomerular basement membrane, causing inflammation and kidney damage.
This document discusses acute renal failure (ARF), also known as acute kidney injury (AKI). It defines ARF, discusses its epidemiology and causes. The main causes of ARF are pre-renal (decreased blood flow/volume), renal (damage within the kidneys), and post-renal (obstruction of urine flow). The most common form of intrinsic ARF is acute tubular necrosis, often due to ischemia or nephrotoxins. Diagnosis involves lab tests of kidney function and urine analysis. Treatment focuses on identifying and reversing the underlying cause, maintaining fluid/electrolyte balance, and potentially initiating renal replacement therapy like dialysis.
This document provides information on the clinical management of a patient presenting with jaundice. It begins by defining jaundice and explaining bilirubin metabolism. Jaundice is classified by the type of circulating bilirubin (conjugated or unconjugated) and site of the problem (prehepatic, hepatocellular, or cholestatic/obstructive). The causes, clinical manifestations, appropriate laboratory tests, and imaging studies are described for each type of jaundice to aid in diagnosis and management. A thorough history, physical exam, and targeted lab and imaging workup are recommended to determine the underlying etiology causing a patient's jaundice.
This document provides guidance on evaluating and approaching a patient presenting with proteinuria. It discusses normal and abnormal levels of protein in the urine and different types of proteinuria including glomerular, tubular, and overflow. For evaluation, it recommends determining the amount and type of protein, and assessing other relevant clinical and lab findings. Extensive workup is suggested for proteinuria accompanied by renal impairment, nonspecific symptoms, or in elderly patients to identify underlying causes like glomerular disease, tubular disorders, paraproteinemias, or malignancy that may require a renal biopsy for diagnosis.
This document discusses the case of a 31-year-old female presenting with stage 2 hypertension. Laboratory tests found her aldosterone level to be elevated at 76 and her plasma renin activity to be less than 0.5, suggesting primary aldosteronism. A CT scan showed a left adrenal adenoma. Adrenal vein sampling found a cortisol corrected aldosterone ratio from the left adrenal vein greater than 4:1, confirming unilateral primary aldosteronism from a left adrenal adenoma. The patient was referred for a laparoscopic left adrenalectomy.
This document discusses the approach to nephrotic syndrome. It describes the case of a 15-year old male patient presenting with swelling of the face and limbs and decreased urine output. Examinations and investigations revealed nephrotic syndrome. A renal biopsy showed membranoproliferative glomerulonephritis. The document then discusses nephrotic syndrome including definitions, classifications of primary and secondary causes, diagnostic workup including renal biopsy, complications of renal biopsy, and treatment approach.
This document discusses the approach and management of thrombocytopenia and immune thrombocytopenic purpura (ITP). It defines thrombocytopenia and its causes, provides diagnostic criteria for ITP, and outlines treatment approaches including corticosteroids, IVIG, anti-D, thrombopoietin receptor agonists, splenectomy, rituximab, and experimental therapies. It also addresses management of severe bleeding, pregnancy-associated thrombocytopenia, and thrombocytopenia in the settings of HIV and hepatitis C infection.
Brain-type Natriuretic Peptide (BNP) - An Information Resource for Cardiac Ne...NHS Improvement
Brain-type Natriuretic Peptide (BNP) - An Information Resource for Cardiac Networks.
Produced by the NHS Heart Improvement Programme, this online document gives a brief overview of available information on Brain-type Natriuretic Peptide (BNP) testing as a ‘rule-out’ measure for echocardiogram when suspecting a diagnosis of heart failure.
(Updated July 2008).
This document provides an overview of heparin-induced thrombocytopenia (HIT). It discusses the history, pathogenesis, frequency, clinical features, diagnosis, and treatment of both type 1 and type 2 HIT. Type 2 HIT is an immune-mediated reaction, where antibodies form against the platelet factor 4-heparin complex, leading to platelet activation and thrombosis. The document outlines various laboratory tests used to diagnose HIT, including functional assays measuring platelet activation and immunoassays detecting antibodies.
Diabetes is the leading cause of end-stage renal disease (ESRD), accounting for over 50% of new ESRD cases. Strict control of blood pressure, blood sugar, cholesterol, and protein in the urine can help prevent or delay kidney damage in patients with diabetes. For patients with diabetes and existing chronic kidney disease, careful management of medications, diet, anemia, bone disease, and other comorbidities is needed. Dialysis or kidney transplantation may be required as kidney function declines.
A 70-year-old woman presented with altered mental status. Her lab work showed abnormalities including a hematocrit of 45%, serum sodium of 147 mEq/L, serum potassium of 5.2 mEq/L, BUN of 70 mg/dl, and serum creatinine of 1.8 mg/dl. She was found to have dry oral mucosa. Based on her lab results and symptoms, she appears to have acute kidney injury likely due to prerenal causes such as dehydration from her minor febrile illness several days prior.
This document provides an overview of acute kidney injury (AKI), formerly known as acute renal failure. It discusses the definition, epidemiology, diagnostic criteria, etiology, pathophysiology, diagnostic evaluation, urine and blood findings, complications, supportive management including nutrition and monitoring, indications for hemodialysis, timing of dialysis initiation, and prognosis. AKI is characterized by sudden impairment of kidney function and retention of waste products. It commonly occurs in hospitalized patients, especially those in the intensive care unit. The most widely used diagnostic criteria are from KDIGO. Common causes include acute tubular necrosis, prerenal azotemia, and acute injury superimposed on chronic kidney disease. Supportive care focuses on fluid
This document presents a case of a 52-year-old female with fluid and electrolyte imbalance. She was admitted for shortness of breath and found to have hyponatremia and pulmonary congestion secondary to heart failure. Laboratory results showed low sodium, high BUN, and abnormal electrolyte ratios. She was diagnosed with hypervolemic hyponatremia and treated with diuretics and fluid restriction, resulting in improved sodium levels over five days. The document then discusses key principles of fluid balance, electrolytes, hypovolemia, and their management.
This document discusses coagulation disorders and bleeding disorders. It describes the normal hemostatic mechanisms including the vascular, platelet and coagulation systems. Bleeding disorders can cause spontaneous or excessive bleeding and can be due to increased vascular fragility, platelet deficiencies or dysfunctions, or derangements of clotting factors. Specific disorders discussed include hemophilia A/B, von Willebrand's disease, and disseminated intravascular coagulation. Laboratory tests that can identify coagulation disorders include the tourniquet test, bleeding time, clotting time, platelet count, clot retraction time, prothrombin time, activated partial thromboplastin time, and thrombin time. Further specific tests may
This document provides an overview of diabetic ketoacidosis (DKA), including its definition, pathophysiology, signs and symptoms, diagnosis, management, and complications. DKA is a life-threatening complication of diabetes caused by insufficient insulin leading to hyperglycemia and ketone accumulation in the blood and urine. Initial management involves fluid resuscitation, insulin therapy, and monitoring to resolve acidosis, lower blood glucose, and reduce ketones before transitioning to subcutaneous insulin. Complications can include cerebral edema, hypokalemia, and venous thromboembolism.
Glomerular diseases refer to conditions that damage the glomeruli, the tiny filtering units in the kidneys. This damage reduces the kidneys' ability to filter waste from the blood, which can cause protein and blood to appear in the urine. Glomerular diseases have various genetic and environmental causes and include glomerulonephritis, which is glomerular inflammation, and glomerulosclerosis, which is glomerular scarring. Symptoms include proteinuria, hematuria, edema, and low blood protein levels. Diagnosis involves urinalysis, blood tests, and potentially a kidney biopsy. Treatment depends on the specific disease but aims to slow kidney damage progression in early stage chronic kidney disease.
Tubulointerstitial nephropathy can be acute or chronic and is characterized by inflammation and scarring of the kidney tubules and surrounding tissue. Acute causes are often toxins or ischemia while chronic causes include obstructive uropathy, vesicoureteral reflux, analgesics, and heavy metals. Polycystic kidney disease is a common hereditary condition where numerous cysts develop in the kidneys, often leading to end-stage renal disease. Medullary sponge kidney is a benign condition present from birth that causes kidney cysts and issues like hematuria, urinary tract infections, and kidney stones.
This document discusses acute renal failure (ARF), also known as acute kidney injury (AKI). It defines ARF, discusses its epidemiology and causes. The main causes of ARF are pre-renal (decreased blood flow/volume), renal (damage within the kidneys), and post-renal (obstruction of urine flow). The most common form of intrinsic ARF is acute tubular necrosis, often due to ischemia or nephrotoxins. Diagnosis involves lab tests of kidney function and urine analysis. Treatment focuses on identifying and reversing the underlying cause, maintaining fluid/electrolyte balance, and potentially initiating renal replacement therapy like dialysis.
This document provides information on the clinical management of a patient presenting with jaundice. It begins by defining jaundice and explaining bilirubin metabolism. Jaundice is classified by the type of circulating bilirubin (conjugated or unconjugated) and site of the problem (prehepatic, hepatocellular, or cholestatic/obstructive). The causes, clinical manifestations, appropriate laboratory tests, and imaging studies are described for each type of jaundice to aid in diagnosis and management. A thorough history, physical exam, and targeted lab and imaging workup are recommended to determine the underlying etiology causing a patient's jaundice.
This document provides guidance on evaluating and approaching a patient presenting with proteinuria. It discusses normal and abnormal levels of protein in the urine and different types of proteinuria including glomerular, tubular, and overflow. For evaluation, it recommends determining the amount and type of protein, and assessing other relevant clinical and lab findings. Extensive workup is suggested for proteinuria accompanied by renal impairment, nonspecific symptoms, or in elderly patients to identify underlying causes like glomerular disease, tubular disorders, paraproteinemias, or malignancy that may require a renal biopsy for diagnosis.
This document discusses the case of a 31-year-old female presenting with stage 2 hypertension. Laboratory tests found her aldosterone level to be elevated at 76 and her plasma renin activity to be less than 0.5, suggesting primary aldosteronism. A CT scan showed a left adrenal adenoma. Adrenal vein sampling found a cortisol corrected aldosterone ratio from the left adrenal vein greater than 4:1, confirming unilateral primary aldosteronism from a left adrenal adenoma. The patient was referred for a laparoscopic left adrenalectomy.
This document discusses the approach to nephrotic syndrome. It describes the case of a 15-year old male patient presenting with swelling of the face and limbs and decreased urine output. Examinations and investigations revealed nephrotic syndrome. A renal biopsy showed membranoproliferative glomerulonephritis. The document then discusses nephrotic syndrome including definitions, classifications of primary and secondary causes, diagnostic workup including renal biopsy, complications of renal biopsy, and treatment approach.
This document discusses the approach and management of thrombocytopenia and immune thrombocytopenic purpura (ITP). It defines thrombocytopenia and its causes, provides diagnostic criteria for ITP, and outlines treatment approaches including corticosteroids, IVIG, anti-D, thrombopoietin receptor agonists, splenectomy, rituximab, and experimental therapies. It also addresses management of severe bleeding, pregnancy-associated thrombocytopenia, and thrombocytopenia in the settings of HIV and hepatitis C infection.
Brain-type Natriuretic Peptide (BNP) - An Information Resource for Cardiac Ne...NHS Improvement
Brain-type Natriuretic Peptide (BNP) - An Information Resource for Cardiac Networks.
Produced by the NHS Heart Improvement Programme, this online document gives a brief overview of available information on Brain-type Natriuretic Peptide (BNP) testing as a ‘rule-out’ measure for echocardiogram when suspecting a diagnosis of heart failure.
(Updated July 2008).
This document provides an overview of heparin-induced thrombocytopenia (HIT). It discusses the history, pathogenesis, frequency, clinical features, diagnosis, and treatment of both type 1 and type 2 HIT. Type 2 HIT is an immune-mediated reaction, where antibodies form against the platelet factor 4-heparin complex, leading to platelet activation and thrombosis. The document outlines various laboratory tests used to diagnose HIT, including functional assays measuring platelet activation and immunoassays detecting antibodies.
Diabetes is the leading cause of end-stage renal disease (ESRD), accounting for over 50% of new ESRD cases. Strict control of blood pressure, blood sugar, cholesterol, and protein in the urine can help prevent or delay kidney damage in patients with diabetes. For patients with diabetes and existing chronic kidney disease, careful management of medications, diet, anemia, bone disease, and other comorbidities is needed. Dialysis or kidney transplantation may be required as kidney function declines.
A 70-year-old woman presented with altered mental status. Her lab work showed abnormalities including a hematocrit of 45%, serum sodium of 147 mEq/L, serum potassium of 5.2 mEq/L, BUN of 70 mg/dl, and serum creatinine of 1.8 mg/dl. She was found to have dry oral mucosa. Based on her lab results and symptoms, she appears to have acute kidney injury likely due to prerenal causes such as dehydration from her minor febrile illness several days prior.
This document provides an overview of acute kidney injury (AKI), formerly known as acute renal failure. It discusses the definition, epidemiology, diagnostic criteria, etiology, pathophysiology, diagnostic evaluation, urine and blood findings, complications, supportive management including nutrition and monitoring, indications for hemodialysis, timing of dialysis initiation, and prognosis. AKI is characterized by sudden impairment of kidney function and retention of waste products. It commonly occurs in hospitalized patients, especially those in the intensive care unit. The most widely used diagnostic criteria are from KDIGO. Common causes include acute tubular necrosis, prerenal azotemia, and acute injury superimposed on chronic kidney disease. Supportive care focuses on fluid
This document presents a case of a 52-year-old female with fluid and electrolyte imbalance. She was admitted for shortness of breath and found to have hyponatremia and pulmonary congestion secondary to heart failure. Laboratory results showed low sodium, high BUN, and abnormal electrolyte ratios. She was diagnosed with hypervolemic hyponatremia and treated with diuretics and fluid restriction, resulting in improved sodium levels over five days. The document then discusses key principles of fluid balance, electrolytes, hypovolemia, and their management.
This document discusses coagulation disorders and bleeding disorders. It describes the normal hemostatic mechanisms including the vascular, platelet and coagulation systems. Bleeding disorders can cause spontaneous or excessive bleeding and can be due to increased vascular fragility, platelet deficiencies or dysfunctions, or derangements of clotting factors. Specific disorders discussed include hemophilia A/B, von Willebrand's disease, and disseminated intravascular coagulation. Laboratory tests that can identify coagulation disorders include the tourniquet test, bleeding time, clotting time, platelet count, clot retraction time, prothrombin time, activated partial thromboplastin time, and thrombin time. Further specific tests may
This document provides an overview of diabetic ketoacidosis (DKA), including its definition, pathophysiology, signs and symptoms, diagnosis, management, and complications. DKA is a life-threatening complication of diabetes caused by insufficient insulin leading to hyperglycemia and ketone accumulation in the blood and urine. Initial management involves fluid resuscitation, insulin therapy, and monitoring to resolve acidosis, lower blood glucose, and reduce ketones before transitioning to subcutaneous insulin. Complications can include cerebral edema, hypokalemia, and venous thromboembolism.
Glomerular diseases refer to conditions that damage the glomeruli, the tiny filtering units in the kidneys. This damage reduces the kidneys' ability to filter waste from the blood, which can cause protein and blood to appear in the urine. Glomerular diseases have various genetic and environmental causes and include glomerulonephritis, which is glomerular inflammation, and glomerulosclerosis, which is glomerular scarring. Symptoms include proteinuria, hematuria, edema, and low blood protein levels. Diagnosis involves urinalysis, blood tests, and potentially a kidney biopsy. Treatment depends on the specific disease but aims to slow kidney damage progression in early stage chronic kidney disease.
Tubulointerstitial nephropathy can be acute or chronic and is characterized by inflammation and scarring of the kidney tubules and surrounding tissue. Acute causes are often toxins or ischemia while chronic causes include obstructive uropathy, vesicoureteral reflux, analgesics, and heavy metals. Polycystic kidney disease is a common hereditary condition where numerous cysts develop in the kidneys, often leading to end-stage renal disease. Medullary sponge kidney is a benign condition present from birth that causes kidney cysts and issues like hematuria, urinary tract infections, and kidney stones.
Acte kidney injury-advances in diagnosis & management.Suneth Weerarathna
This document discusses advances in the diagnosis and management of acute kidney injury (AKI). It begins with objectives and outlines of topics including AKI definitions, classification systems, biomarkers for early detection, and management strategies. Novel biomarkers such as Kim-1, NGAL, and cystatin C allow detection of AKI earlier than serum creatinine. While renal replacement therapy is important for established AKI, prevention and treatment of underlying causes are priorities. Overall, awareness of AKI is increasing worldwide and standardized criteria along with new diagnostics and therapies can lead to better outcomes.
Mixing it Up With Myxomatous Degenerationupstatevet
This document provides an overview of a lecture on myxomatous degeneration. It begins with the clinical history and pathophysiology of the disease, noting that it is the most common cardiac disease in dogs and affects small breed dogs especially. It then discusses developments in understanding the disease pathogenesis, focusing on the roles of serotonin, TGF-beta, endothelial dysfunction, and oxidative damage. The document reviews medical and interventional treatment options and their limitations. It concludes by discussing the potential for new insights into prevention and treatment through better understanding of the disease's genetic and molecular basis.
Small Animal Endocrine Diseases, Dr. Danielle Davignon, 10/10/15upstatevet
This document discusses the latest advances in diagnosing, treating, and monitoring endocrine diseases in small animals. It focuses on feline hyperthyroidism, canine adrenal disorders, diabetes mellitus, and Cushing's disease in cats. Key points include improved diagnostic tests for hyperthyroidism like free T4 levels, treatment options like radioactive iodine therapy and transdermal methimazole, and monitoring hypothyroidism after treatment. For canine Cushing's, the document reviews diagnostic tests, medical therapies of mitotane and trilostane, and advanced treatment with Cyberknife radiation. It also discusses atypical Cushing's and monitoring control with single cortisol measurements.
"Maintaining Sterility During a Surgical Procedure"upstatevet
Maintaining sterility during surgery is essential to prevent infection. Key aspects include creating and maintaining a sterile surgical field, proper cleaning and sterilization of instruments, strict sterile technique among all staff in the operating room, and use of protective attire and drapes. Proper cleaning of instruments and use of steam sterilization or other methods can eliminate microorganisms to achieve sterility. Strict adherence to protocols at each step of preparation, surgery, and cleaning is necessary to protect patients and staff.
What's an Eyeball?: Veterinary Ophthalmology for the LVTupstatevet
This document provides an overview of veterinary ophthalmology for licensed veterinary technicians (LVTs). It begins with basic eye anatomy and then covers various aspects of the gross ocular exam including things that can be observed externally, the 2-foot away exam, and components of the ocular history. It also reviews important diagnostic tests like the Schirmer tear test, tonometry, and fluorescein staining. Key terminology is defined and specific structures like the third eyelid, conjunctiva, pupil, and orbit are examined in detail. Throughout, emphasis is placed on tests and exams that LVTs are qualified to perform.
This document discusses the clinical manifestations and pathophysiology of renal diseases. It begins by defining terms related to azotemia and renal failure. It then describes the major clinical syndromes seen in renal disease such as nephritic syndrome, nephrotic syndrome, asymptomatic urinary findings, rapidly progressive glomerulonephritis, acute renal failure and chronic renal failure. It further discusses the causes, presentations and pathophysiology of acute nephritic syndrome, nephrotic syndrome and glomerular injury from both immunological and non-immunological standpoints.
Diagnosis & Management of the Allergic Cat, Dr. Michelle Tranchina, 11/8/14upstatevet
This document discusses the diagnosis and management of allergic reactions in cats, specifically focusing on cat allergies. It defines allergies and allergens, describes the four types of hypersensitivity reactions, and explains the danger model of allergic disease. It then discusses atopic dermatitis, food allergies, flea allergy dermatitis, and eosinophilic granuloma complex in cats. The diagnosis and treatment of these conditions is explained, including the use of corticosteroids, antihistamines, cyclosporine, and immunotherapy.
This document provides an overview of glomerular diseases, including their anatomy, pathogenesis, classification, and clinical features. It discusses the nephritic and nephrotic disease spectra and specific conditions like minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy, IgA nephropathy, post-streptococcal glomerulonephritis, rapidly progressive glomerulonephritis, and Alport's syndrome. Diagrams and microscopy images are included to illustrate anatomical structures and pathological findings.
What’s New With Pimobendan? Current Research and Treatment Recommendationsupstatevet
This document summarizes current research on the drug pimobendan and its use in treating heart conditions in dogs. It discusses pimobendan's pharmacology and pharmacokinetics. Studies show pimobendan can help dogs with dilated cardiomyopathy and myxomatous mitral valve disease by improving heart function and reducing signs of congestive heart failure. The EPIC trial is evaluating pimobendan's effects in small breed dogs with preclinical heart enlargement from myxomatous valve disease. In summary, pimobendan is an inodilator drug that can benefit dogs with various heart conditions by enhancing cardiac contractility and vasodilation.
The shake down: An in depth look at epilepsyupstatevet
This document provides an in-depth overview of epilepsy in dogs and cats. It defines seizures, describes different seizure types including focal and generalized seizures. It discusses causes of seizures including idiopathic epilepsy which has a genetic basis in some breeds, structural epilepsy caused by brain abnormalities, and reactive seizures triggered by systemic issues. The document outlines testing, treatment including common anti-seizure medications like phenobarbital, and conditions that can mimic seizures.
This document provides an overview of cataracts in dogs, including:
- The anatomy of the lens and different types of cataracts such as nuclear sclerosis and stages of cataract development.
- Common causes of cataracts like age, diabetes, trauma, and genetics.
- Guidelines for when to refer a cataract case for surgery based on the stage of development.
- Details of the cataract surgery procedure and important aspects of pre- and post-operative care to monitor patients and manage complications.
This case involves an 18-year-old female patient who presented with diarrhea, vomiting, fever and drowsiness. Upon examination, she was found to be febrile, tachycardic and had some dehydration. Laboratory tests revealed she had cholera infection as well as acute kidney injury, with rising serum creatinine and electrolyte imbalances. She was treated for cholera, sepsis, seizures and fluid imbalances. Her kidney function deteriorated over 11 days before beginning to recover. The lack of a proper medical history made diagnosis and management more challenging for this unconscious and unattended patient suffering from acute renal failure.
Max Bush presented on new dressings for wound management. He discussed the phases of wound healing and challenges that can impede the process. The moist wound healing paradigm emphasizes keeping wounds moist to facilitate healing rather than letting them dry out. A variety of modern dressings were presented that aim to maintain a moist environment including honey-based dressings, calcium alginate, and vacuum-assisted closure which uses negative pressure. The key is selecting a dressing matched to the characteristics of the individual wound.
Veterinary Rehabilitation, Dr. Laura Perez, 11/8/14upstatevet
The document discusses veterinary rehabilitation, including what it entails, common modalities like laser therapy, ultrasound, electrical stimulation and magnetic therapy, as well as cases that would benefit such as orthopedic issues, neurological problems, geriatric patients, overweight dogs, and dogs needing conditioning. Manual therapies, therapeutic exercises, hydrotherapy, and basic techniques owners can implement at home are also reviewed.
This document discusses glomerular diseases and nephrotic syndrome. It begins by defining common pathological terms used to describe glomerular lesions, such as focal, diffuse, segmental, and proliferative. It then classifies glomerulopathies based on their clinical presentations, including nephrotic syndrome, acute glomerulonephritis, and rapidly progressive glomerulonephritis. Specific glomerular diseases are then discussed in more detail, with poststreptococcal glomerulonephritis and nephrotic syndrome getting the most attention. It provides information on pathogenesis, clinical features, investigations, prognosis, and treatment approaches for different glomerular diseases.
Cardiovascular Effects, Dr. C Sedacca, 4/5/14upstatevet
This document discusses the cardiovascular effects of various systemic diseases, including endocrine, metabolic, infectious/inflammatory, and neoplastic conditions. It provides details on the cardiac pathophysiology, diagnostics, therapy, and prognosis for hyperthyroidism, hypothyroidism, Addison's disease, Cushing's disease, and other conditions. For hyperthyroidism, it describes the enhanced contractility, tachycardia, and potential for heart failure. Hypothyroidism is noted to have opposite effects and rarely causes heart failure. Addison's disease can cause hypotension and arrhythmias due to hypoaldosteronism and hyperkalemia. Cushing's disease may induce hypertension and exacerbate underlying heart
This document discusses cardiopulmonary cerebral resuscitation (CPCR) in dogs and cats. It defines key terms like respiratory arrest and cardiopulmonary arrest. It outlines that overall survival to discharge is around 6-7% for dogs and 3% for cats. The document then discusses the goals and steps of basic life support (BLS) including circulation, airway, and breathing. It also covers advanced life support (ALS) techniques like drug administration, electrical defibrillation, fluid therapy, and monitoring such as ECG and end-tidal CO2. Finally, it summarizes the RECOVER initiative which aimed to establish evidence-based guidelines for small animal CPR.
Cardiopulmonary Cerebral Resuscitation (CPCR) for Veterinary Techniciansupstatevet
Cardiopulmonary Cerebral Resuscitation (CPCR) involves providing artificial respiration and circulation to an animal that is not breathing and has no heartbeat. The document discusses CPCR outcomes, who is at risk, basic life support techniques like chest compressions and airway management, advanced techniques like drug administration and defibrillation, and the RECOVER initiative to improve resuscitation practices. Successful CPCR requires staff preparedness through training, having necessary equipment and supplies readily available, and effective teamwork during a resuscitation attempt.
This document describes a case of a 48-year-old woman with autoimmune hepatitis type 1 who was admitted with abdominal pain, vomiting, and loose stools. She had been diagnosed with autoimmune hepatitis in July 2017 and had multiple admissions since then. On physical examination, she had jaundice and hepatosplenomegaly. Her labs showed features of hepatitis and anemia. She was treated with IV fluids, blood transfusions, and continued steroids. Her condition improved and she was discharged on steroid monotherapy.
Evaluation of proteinuria in children pptShane Watson
The document discusses the glomerular filtration barrier and the mechanisms of proteinuria. It defines normal levels of urinary protein excretion in children and describes different types of proteinuria including glomerular, tubular, and overflow proteinuria. Evaluation and workup of asymptomatic proteinuria is outlined including orthostatic testing, urine dipstick, and quantitative urine protein levels. Management depends on the type and severity of proteinuria.
This document provides information on proteinuria (abnormal amounts of protein in the urine) including its history, physiology, detection, quantification, causes, and diagnostic evaluation. It details the normal mechanisms by which the kidneys filter and reabsorb albumin and other proteins from the blood. Common causes of proteinuria include benign causes like exercise as well as pathological glomerular, tubular, and overflow proteinuria due to various kidney diseases and disorders. The diagnostic approach involves urinalysis, urine protein creatinine ratio, and ruling out transient causes through repeated testing.
A Clinical Approch Towards Certain Urological MaladiesAditij4
The patient presents with polyuria, pyuria, and hematuria. Differential diagnoses include urinary tract infection, nephrolithiasis, glomerulonephritis, and genitourinary tumors. Evaluation includes urinalysis, urine culture and sensitivity, renal ultrasound, and cystoscopy if indicated. The case involves a young male with a history of neurosurgery who undergoes a water deprivation test consistent with central diabetes insipidus.
The document summarizes key information about liver emergencies seen in the emergency department. It covers topics such as definitions of different types of liver failure (acute, chronic, fulminant), common causes of acute liver failure including paracetamol poisoning and viral hepatitis, complications of liver failure like encephalopathy and infections, criteria for liver transplantation in acute liver failure, management of acute liver failure including supportive care and transplantation, spontaneous bacterial peritonitis in patients with cirrhosis, and Budd-Chiari syndrome which is a rare cause of liver failure due to blockage of hepatic veins. Imaging modalities, investigations, and treatment approaches are also discussed for different liver conditions.
A 9-year-old boy was referred for evaluation of recurrent gum bleeding and nose bleeds, and was found to have elevated liver enzymes, hypergammaglobulinemia, and autoantibodies consistent with autoimmune hepatitis. A liver biopsy showed findings characteristic of autoimmune hepatitis. He was started on prednisone and azathioprine for treatment of autoimmune hepatitis type 1.
Management of Chronic Kidney Disorder (CKD)Sharanya Rajan
This document provides an overview of the management of chronic kidney disease (CKD). It defines CKD and describes its most common causes as diabetes mellitus and hypertension. It explains the pathophysiology of CKD as progressive loss of nephrons leading to activation of the renin-angiotensin-aldosterone system and hypertension. The clinical presentation ranges from asymptomatic early on to later symptoms of kidney failure like fluid overload and hyperuremia. Diagnosis involves assessing glomerular filtration rate and looking for signs of kidney damage through blood and urine tests. Treatment aims to control blood pressure and glucose, treat underlying causes, and prevent complications through diet, medications, and renal replacement therapy like dialysis if indicated. Complications discussed
Cirrhosis results from fibrosis and nodular regeneration of the liver. It leads to increased resistance to blood flow within the liver and portal hypertension. Common complications include variceal bleeding, ascites, spontaneous bacterial peritonitis, hepatic encephalopathy, and hepatorenal syndrome. Treatment focuses on managing the complications through medications, dietary changes, paracentesis, and sometimes transplantation. Prognosis depends on disease severity and presence of complications.
basics about chronic liver disease for a pediatrician. fast and easy guide to common causes of chronic liver diseases in children
Please leave a comment if you like it..
This document provides an overview of approaches to evaluating and managing proteinuria. It discusses normal urinary protein excretion and defines different types of proteinuria. Transient, orthostatic, and persistent proteinuria are described along with pathological causes. Evaluation of a patient with proteinuria involves taking a thorough history, physical exam, and lab tests. Total urinary protein can be measured quantitatively through 24-hour urine collection or spot urine protein/creatinine ratio. Management focuses on controlling blood pressure and glycemia as well as lipid levels. Specific therapies may be used depending on the underlying cause of proteinuria.
This document provides an overview of approaches to proteinuria. It discusses normal urinary protein excretion and defines different types of proteinuria. It describes the evaluation of patients with proteinuria including relevant history, exam findings, and lab tests. It also covers detection and measurement of urinary protein. Management involves controlling blood pressure and lipids. The prognosis depends on the underlying cause, with diabetic nephropathy typically progressing to kidney failure over 10-20 years and nephrotic syndrome having a more variable prognosis.
The document is a newsletter from Sandor Lifesciences Pvt. Ltd. announcing new tests and reporting on two clinical cases. It introduces newborn screening tests for various conditions as well as tests for lysosomal storage disorders and non-invasive prenatal testing. It then describes two cases in detail: a child with Wolman disease presenting with liver and adrenal issues, and a child with Lysinuric Protein Intolerance presenting with hyperammonemia. The newsletter concludes by announcing the company's participation in an upcoming pediatric rare disease conference and inviting feedback from customers.
Dear Clinicians,
We are happy to launch our first edition of quarterly newsletter bringing to your exotic clinical cases with unusual symptoms and/or diagnostic findings, or cases involving rare diseases. We will also share with you our recent achievements, the future roadmap and new test launches in the field of rare disorder diagnosis. We hope that you will find this information quite valuable as it may assist you to derive even better patient management.
Thanks for reading!
Team Sandor
This document discusses grape and raisin toxicity in dogs. It provides information on:
- The toxic doses of grapes and raisins for dogs are 0.7 oz/kg for grapes and 0.1 oz/kg for raisins.
- Clinical signs of toxicity include lethargy, vomiting, diarrhea, and acute renal failure.
- The mechanism is unknown but may involve mycotoxins, pesticides, or an inability to metabolize components of the fruits.
- Diagnostics show elevated BUN and creatinine levels and urinalysis abnormalities. Treatment focuses on decontamination, supportive care like IV fluids, and monitoring for renal recovery.
This document provides information about nephrotic syndrome including its definition, causes, signs and symptoms, investigations, management, and complications. Nephrotic syndrome is characterized by proteinuria, hypoalbuminemia, edema, and hyperlipidemia. It can be caused by primary/idiopathic conditions like minimal change disease or secondary causes such as SLE, diabetes, or drugs. Management involves dietary modifications, diuretics, steroid therapy, and immunosuppressive drugs depending on disease severity and response to treatment. Complications include thrombosis, peritonitis, and hypovolemia which require prompt intervention.
Management of Lupus Nephritis involves investigating through urine analysis, renal function tests, serological blood tests, and renal biopsy. Treatment depends on histologic findings and includes immunosuppressants like corticosteroids and cyclophosphamide for induction, then azathioprine or mycophenolate mofetil for maintenance. Response is monitored through urine protein levels and renal function. New guidelines recommend early renal biopsy and mycophenolate as initial therapy.
1. The document provides an overview of renal anatomy and physiology, clinical manifestations of renal diseases, methods for estimating renal function, and common renal disease syndromes.
2. Key aspects of renal anatomy discussed include the structure and function of nephrons, the glomerular filtration barrier, and countercurrent exchange mechanisms.
3. Common clinical signs of renal diseases include edema, hypertension, flank pain, urinary abnormalities, and changes in estimated glomerular filtration rate.
4. Major renal disease syndromes covered are nephrotic syndrome, nephritic syndrome, acute renal failure, and chronic renal failure.
Acute kidney injury (AKI) is a common condition characterized by a sudden decline in kidney function. It affects 5-7% of hospital admissions and 30% of intensive care unit admissions. The top causes of AKI in India are diarrheal diseases, sepsis, malaria, drug toxicity, and hospital-acquired injuries. Treatment focuses on optimizing fluid status and hemodynamics, removing nephrotoxins if possible, and initiating renal replacement therapy as needed based on the underlying cause and severity of AKI.
Nephrotic syndrome is a common pediatric renal condition characterized by proteinuria, hypoalbuminemia, edema, and hypercholesterolemia. The most common causes are minimal change disease and focal segmental glomerulosclerosis. Treatment involves steroid therapy, but many children are steroid resistant or dependent, requiring additional therapies like calcineurin inhibitors or cytotoxic drugs. Renal biopsy helps determine prognosis and guides management, as focal segmental glomerulosclerosis carries a higher risk of steroid resistance. Timely diagnosis and treatment are important to prevent complications like infection.
This document discusses urine analysis including urine collection, 24 hour urine samples, specimen preservation, and urine examination. Key points include:
- Urine is formed in the kidneys and various samples can be collected including early morning, random, 24 hour, and catheterized samples.
- 24 hour urine samples are used to quantitatively estimate proteins, hormones, microalbumin, and metabolites.
- Preservatives like HCl, toluene, and boric acid can be used but may interfere with tests. Samples should be examined within 1-2 hours.
- Urine examination includes macroscopic tests of volume, color, odor, pH; microscopic tests; and chemical tests for proteins, sugars
Similar to Proteinuira & Glomerular Disease, Dr. Sara Arnold, 11/8/14 (20)
Title: Cardiac Emergencies of the Dog and Cat
Presented by: Agnieszka Kent, DVM, MS, DACVIM (Cardiology)
Description: This course will discuss common cardiac emergencies and how to identify and determine the primary problem through effective history-taking, physical examination, and diagnostics. We will discuss how to approach each emergent condition with treatment strategies and monitoring to help you be as successful as possible in helping your patients through these life-threatening conditions.
Uh-oh ... It Went Neuro: Triaging the Acute Neurologic Patientupstatevet
Title: Uh-oh ... It Went Neuro: Triaging the Acute Neurologic Patient
Presented by: Todd Bishop, DVM, DACVIM (Neurology)
Description: This lecture is geared toward primary care veterinarians and will cover recognizing the three most common neurologic emergencies, triaging the severity, and performing an initial neurologic evaluation. The lecture will include initiating a minimum database and basic diagnostic work-up, providing first responder-type therapeutic interventions, and knowing if/when to refer.
Itching, Scratching, Atopy Oh My! Diagnosis and Treatment of the Allergic Pat...upstatevet
Title: Itching, Scratching, Atopy Oh My! Diagnosis and Treatment of the Allergic Patient
Presented by: Amy Schnedeker, DVM, MS, DACVD
Description: This course aims to discuss the work-up of allergy patients, starting from diagnostics and treatment of secondary infections to different medications for managing pruritus and diagnosing underlying allergic diseases - flea allergy versus food allergy versus atopic dermatitis.
Radiographic Positioning and Quality Control of Thoracic, Abdominal, and Orth...upstatevet
Title: Radiographic Positioning and Quality Control of Thoracic, Abdominal, and Orthopedic Studies
Presented by: Amanda Breyette, LVT, BT, FFCP & Adam Isack, LVT, FFCP
Description: Radiographs that are positioned correctly with proper technique give a better representation of anatomy and disease processes. This, in turn, gives the patient a better chance of being treated appropriately. Throughout this course, you will learn the anatomy to be included in each study, proper/improper technique, and how to correct misaligned radiographs.
Pain Management – A Review and What's Newupstatevet
Title: Pain Management – A Review and What's New
Presented by: Mylissa Fitzpatrick, LVT, CCVP, VTS (Emergency)
Description: This pain management course is designed for veterinary technicians wishing to broaden their education on integral pain management options. The lecture will cover patient pain identification, pharmaceutical pain management options, non-pharmaceutical therapies, and alternative modalities. New pain management drugs and their applications will also be discussed.
Title: Diagnostics in Veterinary Oncology
Presented by: Ariana Verrilli, DVM, DACVIM (Oncology)
Description: This session will discuss the various tests currently available in veterinary oncology, from cytology and histopathology to DNA sequencing and genetic testing. We will review the pros and cons of multiple tests, the best use for each test, and how to interpret results. We will also review sample submissions and specific lab requirements as appropriate.
Leptospirosis in Dogs: What's Bloodwork Got to Do with It?upstatevet
Title: Leptospirosis in Dogs: What's Bloodwork Got to Do with It?
Presented by: Ciera Earl, LVT, VTS (Emergency)
Description: Leptospirosis is a common zoonotic disease that can cause serious illness in dogs, other wild animals, and people. Throughout this lecture, we will look at common lab work and provide a better understanding of the values, their meaning, and how it all ties together in diagnosing Leptospirosis. We will also discuss the signs and symptoms, transmission, prevalence, and treatment.
Cortisol: Friend or Foe, An Overview of Cushing's Disease and Addison's Diseaseupstatevet
Title: Cortisol: Friend or Foe, An Overview of Cushing's Disease and Addison's Disease
Presented By: Erica Hunt, LVT, VTS
Description: This lecture will review the physiology of Cushing's and Addison's disease so that the technician can better understand the disease processes. We will also discuss different treatment options and the necessary monitoring.
Presenter: Dr. Madeline Frazier, DVM, DACVECC
Title: Shock and Paw
Description:
What does it mean when we ask, “Is the patient stable?” Identifying shock quickly and accurately is critical for optimizing patient outcome. This lecture will review broad definitions for shock, the types of shock and their pathophysiology, and how to identify the different types of shock (including occult shock). The lecture will also provide guidelines for treatment of the different shock states, as well as modalities of fluid resuscitation.
Presenter: Dr. Christina Scanlon, DVM, DACVIM (Neurology)
Title: Alphabet Soup Myelopathies
Description:
This course will cover signalment, clinical signs, confirmatory diagnostics, and therapies for myelopathic diseases different from the most common IVDD cases. This lecture will help you recognize cases that are more likely to be FCE or ANNPE based on presentation and will discuss recommended testing, prognoses, and therapies. The presentation will also cover one case of a slightly different myelopathy that is less commonly seen overall.
Learning Objectives:
- To be able to recognize clinical signs and signalment for FCE and ANNPE
- To understand imaging characteristics and differences between FCE and ANNPE
- To understand prognostic indicators and recommended therapies for FCE and ANNPE
Presenter: Dr. Andrew Waxman, DVM, DACVIM (Cardiology)
Hosted by Upstate Veterinary Specialties
Session Description:
Congenital heart diseases are abnormalities of the cardiovascular system which are present at birth. The exact underlying factors are not always understood but are suspected of genetic origin in dogs and cats. Some of the most common diseases include patent ductus arteriosus, pulmonic stenosis, subaortic stenosis, tricuspid valve dysplasia, and ventricular septal defects. These conditions can vary from innocent to life-threatening. This lecture will help participants understand the examination findings, the most common treatment options (if available), and breeding considerations regarding congenital heart disease in dogs and cats. There will also be some discussion about innocent murmurs in young patients.
Introducing Diagnostic Ultrasound in General Practiceupstatevet
Chris Ryan, DVM, DACVR
This lecture will begin by reviewing the basic operation of ultrasound equipment with a focus on hardware and software features common to almost all machines. The various settings and controls will be reviewed, along with the effects that these have on overall image quality, and how to utilize these settings to optimize image quality. A roadmap will then be developed for applying ultrasound in everyday general practice, beginning with the basics of evaluation for abdominal or pleural cavity fluid, and proceeding to perform a complete basic abdominal ultrasound exam. Normal sonographic anatomy and measurements will be reviewed, along with a recommended acquisition protocol for submission to teleradiology services.
Tips and Practical Solutions to Dental Challengesupstatevet
Thomas Phillips, DVM, Fellow of the Academy of Veterinary Dentistry 2007
All veterinarians face challenging dental cases. This course will offer options and techniques to successfully accomplish difficult extractions, oronasal fistula, and tips and tricks for dental procedures.
Diagnosing and Treating Canine Incontinence and Urolithsupstatevet
Alison Khoo, BSc, BVMS, DACVIM (Internal Medicine)
Urinary incontinence is a common presenting complaint in veterinary practice. Treatment of refractory cases may become a major source of frustration for both owners and veterinarians. Medical, surgical, and interventional therapeutic options will be discussed.
Respiratory Distress in the Small Animal Patientupstatevet
Danielle Berube, DVM, DACVECC
This presentation will review the many differentials for patients presenting in respiratory distress. The lecture will be organized based on anatomic locations within the airway, including upper airway disorders, pulmonary causes of respiratory distress, and diseases of the pleural space. Within each section, we will focus on the physical examination findings, diagnostic options to localize the disorder, and stabilization techniques for the patient. We will also discuss less common causes of respiratory distress such as acute lung injury (ALI), acute respiratory distress syndrome (ARDS), transfusion related acute lung injury (TRALI) and even some examples of nonrespiratory look-alikes.
An Overview of Lymphoma for the Veterinary Technicianupstatevet
The document discusses lymphoma in veterinary medicine. It begins with an oath for veterinary technicians and then covers topics like the hallmarks of cancer cells, what lymphoma is, contributing factors, diagnosis including different sampling techniques, staging, treatment options like chemotherapy and its adverse effects, and prognosis. It focuses on providing an overview of lymphoma for veterinary technicians.
Erica Zappia, LVT, Internal Medicine
This course will review vital information for the veterinary technician regarding the diagnosis and management of diabetes mellitus. Participants will learn physiology, clinical signs, and laboratory abnormalities of diabetes. Important communication practices between the veterinary technician and the client will be discussed.
Assessment and Treatment of Pain in the Emergency and Critical Care Patientupstatevet
Abby Luvera, LVT, Emergency
This lecture will discuss the importance of treating acute pain in our emergency and critical care patients, with an emphasis on the role of the veterinary technician in the recognition, assessment, and treatment of pain. Participants will learn sources of acute pain and available treatment modalities, as well as common pitfalls and challenges when assessing pain. Participants will also hear options for implementing a pain scoring system for their practice and resources for continued education.
Pattern Recognition and the ECG – Clinical Interpretation for the LVT upstatevet
Aaron Wey, DVM, DACVIM (Cardiology)
This lecture will be useful for both new and experienced LVTs and will review the clinical ECG as used in small animal practice. Lecture topics will begin with suggestions for obtaining a good quality ECG and will finish with recognition of common rhythm abnormalities encountered in companion animal practice. Audience participation will enhance the lecture and allow attendees to test their knowledge acquired during the presentation.
Joe Palamara, DVM, DACVS-SA
Description: Dyspnea is defined as difficulty/labored breathing or shortness of breath, and can be a sign of serious disease of the airway, lungs or heart. This lecture will review the process of diagnosing, stabilizing and further localizing dyspnea in dogs. We will discuss recommendations for surgical correction of components of Brachycephalic Airway Syndrome, as well as salvage procedure for Laryngeal paralysis. With appropriate management, the prognosis for these conditions is generally favorable depending on the degree of severity.
Learning Objectives
- Recognize the clinical signs, associated physiology, and diagnosis related to each condition
- Initial stabilization for patients presenting in airway crisis
- Understand the medical and surgical options for each condition
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
5. ACVIM consensus statement
Microalbuminuria
Testing
If the patient is predisposed to the development of
proteinuria
Chronic illness
Drug administration
Breed predisposition
Conventional testing is equivocal or conflicting
Dogs > 6 years old and cats > 8 years old where increased
vigilance is desired by the veterinarian or owner
6. Predisposed Breeds
Beagles: Amyloidosis, membranoproliferative glomerulonephritis
Bernese: Mesangiocapillary glomerulonephritis
Bull Terrier: Hereditary nephritis
Cocker Spaniel: Hereditary nephritis
Dalmatian: Hereditary nephritis
Doberman: Glomerulosclerosis, cystic glomerular atrophy
English foxhound:Amyloidosis
Greyhound: Glomerular vasculopathy and necrosis
Newfoundland: Glomerulosclerosis
Pembroke Corgi: Cystic glomerular atrophy
Rottweiler : Atrophic glomerulopathy
Samoyed: Hereditary nephritis
Shar Pei: Amyloidosis
SC Wheaten: Proliferative and sclerosing glomerulonephritis
Vanden S and Grauer G “Glomerular Disease.” Nephrology and Urology of Small Animals.
11. The glomerulus
Hormonal regulation of GFR
Vasoconstriction – decreased GFR
Norepinephrine and Epinephrine
Endothelin
Angiotensin II
Vasodilation – increased GFR
Nitric oxide
Prostaglandins
Bradykinin
12. The proximal tubule
Protein absorption
1.5mM/min
Proteinuria and tubular damage
Mesangial toxicity
Tubular overload and hyperplasia
Toxicity
Up-regulation of inflammation
13. Tubular Proteinuria
Proteinuria is mild
UPC < 3
Can occur as a result of systemic disease and
tubular insult
Fanconi’s syndrome
Glycosuria* in the face of euglycemia
Hypokalemia
Hypophosphatemia
Metabolic acidosis
Proteinuria
14. Summary:
Initial Evaluation of Proteinuria
Urinalysis
Urine culture
If patient is currently on antibiotics – consider
culture 5 to 7 days after antibiotics
Penicillins can cause false + urine protein on
dipstick
UPC
Blood pressure?
Beatrice, L., F. Nizi, et al. (2010). "Comparison of urine
protein-to-creatinine ratio in urine samples collected by
cystocentesis versus free catch in dogs." JAVMA
UPC from free catch urine with an inactive sediment was
equivalent to samples obtained by cystocentesis.
20. Littman, M. P. (2011). "Protein-
losing Nephropathy in Small
Animals." Veterinary Clinics of
North America: Small Animal
Practice 41(1): 31-62.
ProposedProposed
workup?workup?
21. IRIS Guidelines:
Consensus Recommendations for the Diagnostic Investigation of Dogs
with Suspected Glomerular Disease
Tier System
Tier 1 –Renal proteinuria without hypoalbuminemia
Tier 1a – subclinical
Tier 1b – with hypertension +/- target organ damage
Tier 2 – Renal proteinuria with hypoalbuminemia,
nonazotemic
Tier 2a – without hypertension
Tier 2b – with hypertension
Tier 3 – Renal proteinuria with renal azotemia
Tier 3a – normotensive, normal albumin
Tier 3b – hypertensive, normal albumin
Tier 3c – hypoalbuminemic +/- hypertension
22. Recommendations for all patients
CBC, Chemistry panel (including electrolytes),
Urinalysis, Urine culture
UPC
4DX (+/- quant C6), leptospirosis titers
“Appropriate, problem-specific investigation of any
concomitant extra-renal diseases or abnormalities
identified by the minimum evaluation”
Samples to consider saving:
EDTA whole blood *Prior to antibiotic therapy*
Serum
Urine
IRIS Guidelines:
Consensus Recommendations for the Diagnostic Investigation of Dogs
with Suspected Glomerular Disease
23. If UPC > 3.5, hypertension, hypoalbuminemia or
Azotemia are present
Imaging: Abdominal ultrasound, 3v thoracic
radiographs
If hypertensive: testing for Cushing’s disease,
consider drug side effects (Proin, EPO),
pheochromocytoma, hyperaldosteronism, fluid
overload, echocardiogram (left ventricular
hypertrophy)
If hypoalbuminemic
Rule out other causes – liver disease, PLE
Consider additional infectious diseases: Babesia,
Bartonella, RMSF
IRIS Guidelines:
Consensus Recommendations for the Diagnostic Investigation of Dogs
with Suspected Glomerular Disease
25. Renal Biopsy
Contraindications
CKD IRIS stage 4
Severe azotemia (creatinine > 5mg/dl)
Severe anemia
Uncorrectable coagulopathy
Discontinue anti-thrombotics for 3d prior to Bx
Recent NSAID administration
Uncontrolled hypertension
Severe hydronephrosis
Large or multiple renal cysts
Perirenal abscess
Extensive pyelonephritis
Inexperienced operator
Incomplete patient immobilization
Cathy Brown, 2007 ACVIM Conference Proceedings
26. IRIS Guidelines
Biopsy analysis
Light microscopy
Electron microscopy
Immunofluorescence
For biopsy kit and sample submission:
International Veterinary Renal Pathology Service
Department of Veterinary Biosciences
The Ohio State University
Columbus, OH 43210
Dr. Rachel Cianciolo rachel.cianciolo@cvm.osu.edu
28. Treatment: IRIS Guidelines
Consensus Recommendations for Standard
therapy of Glomerular Disease in Dogs
Consensus Guidelines for Immunosuppressive
Treatment of Dogs with Glomerular disease
Absent a Pathologic diagnosis
Consensus Recommendations for
Immunosuppressive Treatment of Dogs with
Glomerular Disease Based on Established
Pathology
Consensus Recommendations for Treatment for
Dogs with Serology Positive Glomerular Disease
29. Iris Guidelines: Standard Therapy
ACE inhibitor
Caution is warranted with IRIS stage 4
Benazepril vs. Enalapril
Max dose – 2mg/kg/day
Angiotensin Receptor Blockers
Losartan – 0.125mg/kg/d (azotemic), 0.5mg/kg/d
(nonazotemic)
Telmisartan - 1mg/kg/d
more lipophilic
longer half life
higher affinity for Angiotensin I receptor
30. IRIS Guidelines: Standard Therapy
Monitor for side effects
Hyperkalemia
Azotemia
IRIS stage 1 & 2 – up to 30% increase in creatinine
without modifying therapy
IRIS stage 3 & 4 are less
tolerant of worsening
azotemia
32. IRIS Guidelines: Standard Therapy
Antithrombotic
Aspirin 0.5 - 5mg/kg/day
Plavix 1-3mg/kg/day
Heparin?
Works via enhancement of antithrombin
33. IRIS Guidelines:
Immunosuppression
Absence of Renal Biopsy
Immunosuppression is contraindicated
Familial Nephropathy
Infectious disease
Amyloidosis
Immunosuppression should be considered
Serum Creatinine >3mg/dL
Azotemia is progressive
Hypoalbuminemia is severe (Albumin <2g/dl)
34. Drug options
Glucocorticoids
Mycophenolate
Azathioprine
Cyclophosphamide
Chlorambucil
Peracute or Rapidly progressive glomerular disease
Mycophenolate** +/- prednisolone
Cyclophosphamide +/- prednisolone
Minimum therapy
8 weeks of rapidly acting drug therapy
8 – 12 weeks of slowly acting drug therapy
IRIS Guidelines:
Immunosuppression
35. Treatment: Hypertension
Geigy C. “Occurrence of systemic hypertension in dogs
with acute kidney injury and treatment with amlodipine
besylate.” JSAP, (2011) 52, 340–346
37. Prognosis
Klosterman (2011). "Comparison of Signalment,
Clinicopathologic Findings, Histologic Diagnosis, and
Prognosis in Dogs with Glomerular Disease with or without
Nephrotic Syndrome." JVIM
38. Prognosis
Syme (2006). "Survival of Cats with Naturally
Occurring Chronic Renal Failure Is Related to
Severity of Proteinuria." JVIM
UPC was significantly associated with survival
39. Prognosis
Jacob (2005). "Evaluation of the association
between initial proteinuria and morbidity rate or
death in dogs with naturally occurring chronic
renal failure." JAVMA
At initial diagnosis of CKD,
dogs with a UPC > 1.0
have significantly shortened
survival relative to dogs
with a UPC <1.0 (300d vs.
600d until renal associated
death)
40. References
Lees, G.E., et al., Assessment and Management of
Proteinuria in Dogs and Cats: 2004 ACVIM Forum
Consensus Statement (Small Animal). Journal of
Veterinary Internal Medicine, 2005. 19(3): p. 377-
385.
IRIS consensus statements. Journal of Veterinary
Internal Medicine, 2013; 27: p S27 – S43
Open access
www.acvim.org
JVIM
Consensus Statements – Wiley Online
41. References
Littman, M.P., Protein-losing Nephropathy in Small Animals. Veterinary Clinics of North America: Small Animal Practice, 2011. 41(1): p. 31-62.
Klosterman, E.S., et al., Comparison of Signalment, Clinicopathologic Findings, Histologic Diagnosis, and Prognosis in Dogs with Glomerular Disease with or without
Nephrotic Syndrome. Journal of Veterinary Internal Medicine, 2011: p. no-no.
Atkins, C.E., et al., Renal effects of Dirofilaria immitis in experimentally and naturally infected cats. Veterinary Parasitology, 2011. In Press, Corrected
Proof.
Zatelli, A., et al., Evaluation of a urine dipstick test for confirmation or exclusion of proteinuria in dogs. American Journal of Veterinary Research, 2010. 71(2): p.
235-240.
Smets, P.M.Y., et al., Urinary Markers in Healthy Young and Aged Dogs and Dogs with Chronic Kidney Disease. Journal of Veterinary Internal Medicine, 2010.
24(1): p. 65-72.
Smets, P.M.Y., et al., Effect of sampling method and storage conditions on albumin, retinol-binding protein, and N-acetyl-{beta}-D-glucosaminidase concentrations in canine
urine samples. J Vet Diagn Invest, 2010. 22(6): p. 896-902.
Raila, J., et al., Influence of kidney function on urinary excretion of albumin and retinol-binding protein in dogs with naturally occurring renal disease. American Journal
of Veterinary Research, 2010. 71(11): p. 1387-1394.
Lyon, S.D., et al., Comparison of urine dipstick, sulfosalicylic acid, urine protein-to-creatinine ratio, and species-specific ELISA methods for detection of albumin in urine
samples of cats and dogs. Journal of the American Veterinary Medical Association, 2010. 236(8): p. 874-879.
Lien, Y.-H., T.-Y. Hsiang, and H.-P. Huang, Associations among systemic blood pressure, microalbuminuria and albuminuria in dogs affected with pituitary- and
adrenal-dependent hyperadrenocorticism. Acta Veterinaria Scandinavica, 2010. 52(1): p. 61.
Lavoué, R., et al., Progressive Juvenile Glomerulonephropathy in 16 Related French Mastiff (Bordeaux) Dogs. Journal of Veterinary Internal Medicine, 2010.
24(2): p. 314-322.
Glassock, R.J., The Pathogenesis of Idiopathic Membranous Nephropathy: A 50-Year Odyssey. American Journal of Kidney Diseases, 2010. 56(1): p. 157-167.
Beatrice, L., et al., Comparison of urine protein-to-creatinine ratio in urine samples collected by cystocentesis versus free catch in dogs. Journal of the American
Veterinary Medical Association, 2010. 236(11): p. 1221-1224.
Bacic, A., et al., Evaluation of albuminuria and its relationship with blood pressure in dogs with chronic kidney disease. Veterinary Clinical Pathology, 2010. 39(2):
p. 203-209.
42. References
Alchi, B. and D. Jayne, Membranoproliferative glomerulonephritis. Pediatric Nephrology, 2010. 25(8): p. 1409-1418.
Jepson RE, B.D., Vallance C, Syme HM, Elliott J., Evaluation of predictors of the development of azotemia in cats. Journal of
Veterinary Internal Medicine, 2009. 23(4): p. 806 - 13.
White, J.D., et al., Persistent haematuria and proteinuria due to glomerular disease in related Abyssinian cats. Journal of Feline
Medicine & Surgery, 2008. 10(3): p. 219-229.
Whittemore, J.C., et al., Association of microalbuminuria and the urine albumin-to-creatinine ratio with systemic disease in cats.
Journal of the American Veterinary Medical Association, 2007. 230(8): p. 1165-1169.
Nabity, M.B., et al., Day-to-Day Variation of the Urine Protein: Creatinine Ratio in Female Dogs with Stable Glomerular
Proteinuria Caused by X-Linked Hereditary Nephropathy. Journal of Veterinary Internal Medicine, 2007. 21(3): p. 425-430.
King, J.N., et al., Prognostic Factors in Cats with Chronic Kidney Disease. Journal of Veterinary Internal Medicine, 2007.
21(5): p. 906-916.
Whittemore, J.C., et al., Evaluation of the association between microalbuminuria and the urine albumin-creatinine ratio and systemic
disease in dogs. Journal of the American Veterinary Medical Association, 2006. 229(6): p. 958-963.
Syme, H.M., et al., Survival of Cats with Naturally Occurring Chronic Renal Failure Is Related to Severity of Proteinuria.
Journal of Veterinary Internal Medicine, 2006. 20(3): p. 528-535.
Vaden, S.L., et al., Renal Biopsy: A Retrospective Study of Methods and Complications in 283 Dogs and 65 Cats. Journal of
Veterinary Internal Medicine, 2005. 19(6): p. 794-801.
Jacob, F., et al., Evaluation of the association between initial proteinuria and morbidity rate or death in dogs with naturally
occurring chronic renal failure. Journal of the American Veterinary Medical Association, 2005. 226(3): p. 393-400.
D'Amico, G. and C. Bazzi, Pathophysiology of proteinuria. Kidney International, 2003. 63(3): p. 809-825.
Grauer, G.F., et al., Effects of Enalapril versus Placebo as a Treatment for Canine Idiopathic Glomerulonephritis. Journal of
Veterinary Internal Medicine, 2000. 14(5): p. 526-533.
Brown, C. Renal Biopsy: Who, When and How? in ACVIM Forum. 2007. Seattle, WA.
Bonagura, J.T., David, ed. Kirk's Current Veterinary Therapy. 14 ed. 2009, Elsevier: St. Louis.
Greene, C.E., ed. Infectious Diseases of the dog and cat. 3 ed. 2006, Elsevier: St. Louis.
False positives on the urine dipstick can occur with alkalinuria and highly concentrated urine
Common sense regarding workup and degree of proteinuria
Beatrice 2010 JAVMA – inactive urine sediment ( &lt; 5RBC / Hpf, &lt; 5WBC / hpf and no visible bactiuria or increased cellularity) FC sample was acceptable for UPC
Microalbuminuria is defined as a protein level greater than normal but lower than can be detected by other standard assays. The problem is we don’t know what normal is. In humans, urine albumin : creatinine ratios greater than 0.03 are considered abnormal
Mechanism behind physiologic proteinuria is not completely understood but it is thought to be a combination f renal vasoconstriction, ischemia and congestion
Renal neoplasia, pyelonephritis and leptospirosis may also produce active urine sediments but be causes of true renal proteinuria and they cause direct damage to the glomerulus and tubules
Filtration barrier is composed of: endothelium, basement membrane and podocytes
The filtration slits are thought to be 8nm in diameter and albumin is only 6nm, it is the negative charge that prevents its filtration
Epinephrine and norepinephrine are elevated in times of high sympathetic tone – only have a real effect on GFR in extreme situations (severe hemorrhage)
Endothelin – released in response to endothelial damage, can be systemically elevated during acute renal failure, chronic uremia, pregnancy toxemia
Angiotensin II – preferentially constricts the efferent arteriole; is secreted in times of decreased arterial pressure and volume depletion in order to prevent decreases in the glomerular hydrostatic pressure and GFR; Constriction of the efferent arteriole increases the filtration fraction in the glomerulus and thereby increases the concentrations of proteins and the colloid osmotic pressure that is delivered to the proximal tubule.
Prostaglandins – oppose vasoconstriction of the afferent arteriole and thereby prevent excessive reduction of GFR
Toxicity – specific proteins, transferrin and iron, may be directly toxic to the tubular epithelial cells
Inflammation may be up regulated by the proteins that accumulate in the proximal tubular cells, also complement components that are filtered through the glomerulus may cause interstitial injury
Monitoring for progression of azotemia in mildly azotemic dogs or non – azotemic dogs serves to provide prognotic information – ongoing kidney damage or stable proteinuria?
UPC can vary up to 40% in dogs and up to 90% in cats from day to day
2011 veterinary parasitology article – naturally and experimentally infected cats with heartworm, the majority had microalbuminuria and 9/10 had UPC &gt; 0.4; unfortunately no UPC data was available for naturally infected but they did test positive for proteinuria via dipstick and there was a weak correlation of the magnitude of infection with degree of proteinuria
** lepto causes primarily tubular proteinuria but the hypoalbuminemia associated with this disease can mimic glomerular disease.
**Potential cross Rxn between Lyme and lepto antibodies.
Humans with chronic kidney disease have an increased complication rate with biopsy
Primarily indicated for episodes of acute renal failure or with glomerulonephritis
- acute renal failure – intact basement membrane is a good indicator for return of renal function but without this the prognosis is much poorer
Complication rate of 15 – 18% - Vaden 2005, most common complication was hemorrhage
Angiotensin receptor blockers act synergistically with ACE inhibitors and can decrease proteinuria by 60% more than either drug alone. However studies in people have shown a higher mortality in elderly patients when given these medications in combination.
Goal is a UPC reduction by 50% or more
Mycophenolate is more widely used for glomerular disease in people and is at least as effective as protocols employing azathioprine, cyclophosphamide and cyclosporine
There was no difference in survival between azotemic dogs with or without nephrotic syndrome
Syme 2006 – used UPC cutoffs of &gt;0.2 and &lt; 0.4 – 3 times more likely to die; &gt;0.4 were 4 times more likely
Based on their graphs, cats with elevated UPC had a 400 – 500 day median survival vs. 1000 d for &lt;0.2 UPC
Only 45 dogs in the entire study. Also appeared to be an association with progressively elevating creatinine and elevated UPC. Time to first uremic crisis was also significantly shorter for dogs with elevated UPC.